Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TINDALL, R. S.A.
Right arrow Articles by ROSENBERG, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TINDALL, R. S.A.
Right arrow Articles by ROSENBERG, R. N.
NEUROLOGY 1978;28:273
© 1978 American Academy of Neurology

Serum antibodies to cytomegalovirus in myasthenia gravis

Effects of thymectomy and steroids

RICHARD S.A. TINDALL, M.D., ROBERT CLOUD, B.S., JAMES LUBY, M.D. and ROGER N. ROSENBERG, M.D.

Departments of Neurology and Internal Medicine (Infectious Disease), Southwestern Medical School, University of Texas Health Science Center at Dallas, Dallas, Texas.

The etiology of the immunologic abnormalities in myasthenia gravis (MG) remains unknown. Evidence for persistent viral infection was sought by determining serum antibody titers to several enveloped RNA and DNA viruses. Compared to healthy controls matched for age, sex, geography and socioeconomic status, patients with MG were more likely to have elevated titers of complement-fixing antibody to cytomegalovirus (CMV). Patients with MG not treated with thymectomy or steroids had elevated CMV titers, whereas thymectomized or steroid-treated patients did not; the differences were statistically significant (p<0.01). These results are consistent with the hypothesis that there is persistent viral antigenic stimulation in the myasthenic thymus, arising from viral protein incorporation into epithelioid-myoid cell surface membranes and subsequent induction of an antibody to these acetylcholine receptor (AChR)-bearing thymic cells. This antibody then cross-reacts with AChR at the neuromuscular junction.

Dr. Tindall's address is Department of Neurology, Southwestern Medical School, University of Texas Health Science Center at Dallas, Dallas, TX 75235.

Mr. Cloud is the recipient of a Dr. Henry R. Viets Medical Student Fellowship from the Myasthenia Gravis Foundation, sponsored by the Greater Dallas-Fort Worth Chapter.

This work was supported in part by NIH grant 1 PO1 CA 17065-02.

Accepted for publication November 4, 1977.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.